Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Cold Chain Distribution

03 Dec 2012 - 04 Dec 2012 - London, UK



Bookmark and Share


The SMi Group Presents their 7th Annual 

Cold Chain Distribution - Europe’s Premier Event

Following the success of last year’s event, the SMi’s Cold Chain Distribution is set to have its best year yet. With leading members of the industry gathering together to discuss, learn and explore the industry, the conference provides a fantastic forum for the most up to date look at cold chain technologies, innovations and management strategies.

This year’s conference will focus on the emerging technologies in the industry, improving the efficiency of the cold chain process, ensuring quality of pharmaceutical products, and the latest in regulations and risk assessments. Perhaps most exciting, is the introduction of 6 new conference sessions, set to give the best opportunities to network, discover and share the latest in the cold chain process.

New for 2012

A Site Visit to the World Courier distribution site: This year you will have the opportunity visit one of World Courier’s biggest sites, situated at Heathrow Airport. You will observe live operations to get a true understanding of the handling of your product throughout its distribution. 

Key Reasons to Attend

Explore the new regulations in cold chain, and how to ensure compliance throughout distribution 

Learn of the hidden regulations in global supply chain, and how to navigate them to ensure compliance

Get Insights into the ways that pharmaceutical companies ensure the safety and effective transportation of pharmaceutical products despite challenges and issues that are faced

See the latest technology innovations in packaging, storage, temperature monitoring and transportation and how they can benefit your company’s supply chain 

Hear about Good Distribution Practices in the industry and how they can be applied to all aspects the cold chain distribution process to create a smooth transition in each stage of transport 

Discuss risk assessments, predictive models, and adaptability of the transport chain to ensure the minimum risk and maximum efficiency of the transport of pharmaceutical goods 

Quote “Technology Network” and save £100

Register online here: http://www.smi-online.co.uk/goto/2012coldchain17.asp



Further information
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!